101 - 125 of 56.083
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Nike Call 74,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,81x
- Analysis
- Nike Call 72,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,83x
- Analysis
- Nike Call 70,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,78x
- Analysis
- Nike Call 68,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,79x
- Analysis
- Nike Call 62,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,70x
- Analysis
- Nike Call 60,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,64x
- Analysis
- Nike Call 76,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,83x
- Analysis
- Nike Call 64,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,68x
- Analysis
- Nike Call 66,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,72x
- Analysis
- Nike Call 82,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,27x
- Analysis
- Nike Call 86,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,38x
- Analysis
- Nike Call 58,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,59x
- Analysis
- Nike Call 80,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,25x
- Analysis
- Novo Nordisk Call 340,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,04x
- Analysis
- Nike Call 78,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,23x
- Analysis
- Nike Call 72,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,15x
- Analysis
- Nike Call 58,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,83x
- Analysis
- Nike Call 84,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,38x
- Analysis
- Nike Call 56,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,59x
- Analysis
- Nike Call 56,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,77x
- Analysis
- Nike Call 68,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,07x
- Analysis
- Nike Call 60,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,90x
- Analysis
- Nike Call 70,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,07x
- Analysis
- Nike Call 66,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,03x
- Analysis
- Novo Nordisk Call 380,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,67x
- Analysis